Ghadeer Dawwas, PhD, MSc, MBA, is an assistant professor of medicine in the Division of Epidemiology, Department of Medicine, at Vanderbilt University Medical Center. She is a faculty scholar at the Vanderbilt Center for Health Services Research (CHSR), and a member of Vanderbilt Translational and Clinical Cardiovascular Research Center (VTRACC).

Dr. Dawwas holds PhD and MSc degrees in pharmacoepidemiology from the University of Florida, an MBA from Stratford University, and a bachelor’s degree in pharmacy from the University of Jordan. She completed her postdoctoral fellowship at the Perelman School of Medicine at the University of Pennsylvania.

Dr. Dawwas is a pharmacoepidemiologist and her research program uses readily available health care data to provide stakeholders including patients, clinicians, payers and policymakers with evidence on the risk/benefit tradeoffs of therapeutic alternatives to improve clinical decision-making. The major themes of her research center on the evaluation of anticoagulants, research methods, and the intersection of comparative effectiveness research and health policy. Her most notable contribution stems from the work that evaluated apixaban and rivaroxaban in patients with venous thromboembolism (VTE) that, among other evidence, led CVS Caremark to reverse its decision regarding the removal of apixaban from CVS preferred formulary list.

Dr. Dawwas' work resulted in notable peer-reviewed manuscripts published in Annals of Internal Medicine, Diabetes Care, and Lancet Hematology. She is a section editor of the Journal of Thrombosis and Thrombolysis. Currently, she serves as the PI of two grants funded by the National Heart, Lung, and Blood Institute (NHLBI) and the American Society of Hematology (ASH) that aim to improve VTE treatment and prevention in populations historically excluded from randomized clinical trials.

Dr. Dawwas is the recipient of several awards from national and international organizations including fellowships from the ASH and American Association of University Women (AAUW), Best Article of the Month by Emergency Medicine Reviews and Perspectives, Paper of the Year by American Association of Colleges of Pharmacy (ACCP), International Society for Pharmacoepidemiology (ISPE) Second Best Abstract Award, International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Top Research Presentation, and Phi Kappa Phi Love of Learning Award.

Education

MSc - Master in Pharmaceutical Sciences, University of Florida, 2017
PhD - University of Florida, 2018
Fellowship - Biostatistics Epidemiology and Informatics, University of Pennsylvania, 2022

Jordan Anderson MD, MBA, MPhil, is an assistant professor of clinical medicine and hospitalist in the Division of General Internal Medicine and Public Health at Vanderbilt University Medical Center. He received his bachelor's degree at Auburn University, his master's degree in medical anthropology at Oxford University as a Rhodes Scholar, and his medical degree at Harvard Medical School. He completed his internship and residency training in Internal Medicine at Brigham and Women's Hospital in Boston, where he concurrently completed his MBA at Harvard Business School.

Dr. Anderson has conducted health services and outcomes research focused on health policy, payment reform, medical education and health care delivery with his writing and research published in the New England Journal of Medicine, Journal of General Internal Medicine, CHEST, Healthcare and Academic Medicine.

Dr. Anderson's interests are in clinical model innovation and improving care delivery for high-risk, complex patient populations. He has experience working in population health and value-based care, and helped to develop Accountable Care Organizations (ACOs). He has worked with startup, value-based care delivery companies including Belong Health, where his work focuses on building more supportive care programs for Medicare and Dual Eligible (Medicare and Medicaid) patient groups.

MD - Harvard University, 2018
Residency - Internal Medicine, Brigham & Women's Hospital, 2022

Dr. McKay (she/her) is Associate Professor of Medicine, Health, and Society and Health Policy (secondary), Director of the LGBTQ+ Policy Lab, and Associate Director of the Center for Research on Inequality and Health at Vanderbilt University. She is a sociologist and demographer who is nationally recognized for her expertise in the field of LGBTQ+ population health, policy, and aging. She is a co-founder of the Vanderbilt LGBTQ+ Policy Lab, which was recently recognized by the National Institutes of Health for for its advances in LGBTQ+ health research. She has expertise in LGBTQ+ health and aging, HIV policy, and firearm injury.